sparfloxacin has been researched along with Dermatitis, Contact, Phototoxic in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (23.53) | 18.2507 |
2000's | 9 (52.94) | 29.6817 |
2010's | 4 (23.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, MA; Domagala, JM; Gogliotti, RD; Gracheck, SJ; Huband, MD; Sanchez, JP; Sesnie, JA; Shapiro, MA | 1 |
Forster, R; Gerbeix, C; Pearson, N; Thirion-Delalande, C; Turnock, S | 1 |
Pawar, M; Singh, M | 1 |
Bauer, D; Boudon, SM; Junker, U; Morandi, G; Odermatt, A; Prideaux, B; Staab, D; Stoeckli, M | 1 |
Khaĭmenov, AIa; Khaĭmenova, TIu; Lazareva, IaV; Sokolova, GB | 1 |
Akimoto, A; Kawashima, H; Kim, S; Matsumoto, N | 1 |
Hayakawa, H; Kawamura, Y; Miyazaki, M; Nagasawa, M; Nakamura, S; Nojima, Y | 1 |
Li, JL; Ma, XC; Tu, ZH; Xin, J; Zhang, T | 1 |
Dawe, RS; Ferguson, J; Ibbotson, SH; Sanderson, JB; Thomson, EM | 1 |
Furuhama, K; Goto, K; Jindo, T; Sekiguchi, M; Yabe, K | 1 |
Iwamoto, Y; Mizutani, K; Takigawa, M; Tokura, Y | 1 |
Kato, M; Nomura, M; Shimoda, K | 1 |
Asahig, K; Hamanaka, H; Mizutani, H; Shimizu, M | 1 |
Bégaud, B; Moore, N; Pierfitte, C; Royer, RJ | 1 |
Ikeda, T; Kato, M; Okawara, S; Shimoda, K | 1 |
Arora, VK; Gupta, R; Gupta, S; Singla, R | 1 |
Yagawa, K | 1 |
1 review(s) available for sparfloxacin and Dermatitis, Contact, Phototoxic
Article | Year |
---|---|
Latest industry information on the safety profile of levofloxacin in Japan.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Infective Agents; Central Nervous System; Chemical and Drug Induced Liver Injury; Dermatitis, Phototoxic; Drug Industry; Fluoroquinolones; Heart Diseases; Humans; Japan; Levofloxacin; Naphthyridines; Ofloxacin; Seizures; Substance Withdrawal Syndrome | 2001 |
3 trial(s) available for sparfloxacin and Dermatitis, Contact, Phototoxic
Article | Year |
---|---|
[Sparfloxacin in combined therapy for pulmonary tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Arrhythmias, Cardiac; Dermatitis, Phototoxic; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2008 |
A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity.
Topics: Adult; Anti-Bacterial Agents; Asian People; China; Dermatitis, Phototoxic; Dose-Response Relationship, Drug; Drug Administration Schedule; Enoxacin; Female; Fluoroquinolones; Follow-Up Studies; Humans; Japan; Levofloxacin; Light; Male; Middle Aged; Ofloxacin; Scotland; Single-Blind Method; Skin Tests; Statistics, Nonparametric; White People | 2003 |
Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Culture Media; Dermatitis, Phototoxic; Drug Therapy, Combination; Ethionamide; Fluoroquinolones; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
13 other study(ies) available for sparfloxacin and Dermatitis, Contact, Phototoxic
Article | Year |
---|---|
The synthesis, structure-activity, and structure-side effect relationships of a series of 8-alkoxy- and 5-amino-8-alkoxyquinolone antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Bacteria; CHO Cells; Cricetinae; Dermatitis, Phototoxic; Drug Design; Female; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Quinolones; Structure-Activity Relationship | 1995 |
Assessment of phototoxicity in pigmented Long-Evans rat: sparfloxacin and 8-methoxypsoralen.
Topics: Animals; Cell Proliferation; Dermatitis, Phototoxic; Eye; Female; Fluoroquinolones; Lymph Nodes; Methoxsalen; Pigmentation; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Skin; Ultraviolet Rays | 2018 |
Sparfloxacin-induced photo-onycholysis and photosensitivity characteristically sparing lepromatous skin lesions: an interesting observation.
Topics: Adult; Anti-Infective Agents; Dermatitis, Phototoxic; Fluoroquinolones; Humans; Leprosy, Borderline; Male; Onycholysis | 2018 |
Evaluation of sparfloxacin distribution by mass spectrometry imaging in a phototoxicity model.
Topics: Animals; Dermatitis, Phototoxic; Disease Models, Animal; Ear; Edema; Female; Fluoroquinolones; Humans; Mass Spectrometry; Mice; Mice, Inbred BALB C; Models, Anatomic; Molecular Imaging; Skin; Tissue Distribution | 2014 |
Comparative study of skin phototoxicity with three drugs by an in vivo mouse model.
Topics: 3T3 Cells; Animals; Antitubercular Agents; Dermatitis, Phototoxic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ear, External; Female; Fibroblasts; Fluoroquinolones; Humans; Mice; Mice, Inbred BALB C; Photosensitizing Agents; Quinolines; Radiography; Skin; Ultraviolet Rays | 2010 |
[Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Dermatitis, Phototoxic; Enoxacin; Female; Fluoroquinolones; Guinea Pigs; Nalidixic Acid; Ofloxacin; Oxazines; Quinolones; Rats; Rats, Sprague-Dawley; Ultraviolet Rays | 2002 |
Reliability of phototoxic tests of fluoroquinolones in vitro.
Topics: 3T3 Cells; Animals; Anti-Infective Agents; Ciprofloxacin; Cricetinae; Cricetulus; Dermatitis, Phototoxic; Female; Fluoroquinolones; Mice; Mice, Inbred BALB C; Micronucleus Tests; Norfloxacin; Quinolones; Rats; Rats, Wistar; Ultraviolet Rays | 2003 |
Structure-phototoxicity relationship in Balb/c mice treated with fluoroquinolone derivatives, followed by ultraviolet-A irradiation.
Topics: Animals; Anti-Bacterial Agents; Dermatitis, Phototoxic; Dose-Response Relationship, Drug; Ear; Female; Fluoroquinolones; Histocytochemistry; Mice; Mice, Inbred BALB C; Structure-Activity Relationship; Ultraviolet Rays | 2005 |
Sparfloxacin phototoxicity: potential photoaugmentation by ultraviolet A and B sources.
Topics: Animals; Anti-Infective Agents; Dermatitis, Phototoxic; DNA Damage; DNA, Single-Stranded; Fluoroquinolones; Male; Mice; Mice, Inbred BALB C; Quinolones; Ultraviolet Rays | 1996 |
Effect of antioxidants, anti-inflammatory drugs, and histamine antagonists on sparfloxacin-induced phototoxicity in mice.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arachidonic Acid; Dermatitis, Phototoxic; Female; Fluoroquinolones; Histamine Antagonists; Histamine Release; Mast Cells; Mice; Mice, Inbred BALB C; Photosensitivity Disorders; Quinolones; Reactive Oxygen Species; Retinal Degeneration; Skin; Ultraviolet Rays | 1996 |
Melanocyte melanin augments sparfloxacin-induced phototoxicity.
Topics: Anti-Infective Agents; Cell Survival; Dermatitis, Phototoxic; Drug Hypersensitivity; Fluoroquinolones; Humans; Melanins; Melanocytes; Melanoma; Melanoma, Amelanotic; Tumor Cells, Cultured; Ultraviolet Rays | 1999 |
The link between sunshine and phototoxicity of sparfloxacin.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Infective Agents; Child; Dermatitis, Phototoxic; Epidemiologic Studies; Female; Fluoroquinolones; France; Humans; Male; Middle Aged; Sunlight; Ultraviolet Rays | 2000 |
Possible relationship between phototoxicity and photodegradation of sitafloxacin, a quinolone antibacterial agent, in the auricular skin of albino mice.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Dermatitis, Phototoxic; Female; Fluoroquinolones; Mice; Mice, Inbred BALB C; Photolysis; Quinolones; Time Factors; Ultraviolet Rays | 2000 |